Chronic Idiopathic Constipation (CIC) Treatment Market To Witness Strong Growth Due To Rise In Prevalence Of Chronic Constipation

 

Chronic Idiopathic Constipation (CIC) Treatment Market
Chronic Idiopathic Constipation (CIC) Treatment Market

Overview:

Chronic idiopathic constipation (CIC) is classified as one of the functional gastrointestinal disorders, meaning that testing does not identify an abnormality in the digestive system. Management of CIC includes patient education, dietary changes and laxatives as well as behavior modification. The primary goal of chronic idiopathic constipation treatment is to improve the bowel movement frequency, ease of passing stool and control the pain and abdominal discomfort from constipation.

Market Dynamics:

The growing number of old age population across the globe is expected to propel growth of the global chronic idiopathic constipation (CIC) treatment market during the forecast period. Old age population is highly susceptible to suffering from CIC, as they use analgesics such as hydromorphone, morphine, codeine like prescription for chronic pain. This in turn affects their digestive system, due to which they are likely to suffer from CIC. Thus, this factor is projected to support growth of the market. For instance, as per the World Bank data, the geriatric population increased from 9.102% in 2019 to 9.321% in 2020, which is 723,184,486.

However, the decline in healthcare expenditure in some of the developing countries is anticipated to hinder growth of the global chronic idiopathic constipation (CIC) treatment market during the forecast period.

Impact of COVID-19:

The outbreak of the pandemic affected more than 200 countries across the world, and as a result the number of patient visits reduced everywhere. Moreover, the demand for constipation treatment also declined during the pandemic, which adversely affected growth of the chronic idiopathic constipation (CIC) treatment market. However, in some of the COVID-19 infection cases, the need for constipation treatment was emerging. Thus, the outbreak of COVID-19 and subsequent symptoms of irritable bowel syndrome or constipation are likely to drive growth of the market in the near future.

Key Takeaways:

·         The global chronic idiopathic constipation (CIC) treatment market is anticipated to grow with a CAGR of 7.0% during the forecast period, due to rise in cases of chronic constipation health disorders. For instance, as per the National Center for Biotechnology Information, the average prevalence of constipation among adults is estimated as 16% across the world, and 33.5% of prevalence was among adults aged 60 to 110 years.

·         Among regions, North America is expected to show significant growth in the global chronic idiopathic constipation (CIC) treatment market during the forecast period, owing to growing cases of chronic constipation in the region, and rise in investment in healthcare sector.

·         Key players functioning in the global chronic idiopathic constipation (CIC) treatment market are Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Ltd., Janssen Pharmaceutical Company, Ironwood Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Pfizer Inc., Abbott Laboratories, Valeant Pharmaceuticals International Inc., AstraZeneca Plc, Bayer AG, Cosmo Pharmaceuticals NV, and Sanofi S.A.

Comments

Post a Comment

Popular posts from this blog

Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Image
Molecular Cytogenetics Market Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular t...
Read more

Bispecific Antibodies Are Used As Therapeutic Drugs While Treating Viral Infections, Oncology, And Auto-Immune Diseases

Image
  Bispecific Antibodies Bispecific antibodies are produced through cell fusion or recombinant DNA technologies. Bispecific antibodies are much more specific than monoclonal antibodies. Their applications in tumor immunotherapy are nearly limitless. As of today, seven bispecific antibodies have been approved by the FDA and EMA and over one hundred are in preclinical testing. Bispecific antibodies were initially developed using the quadroma technology. They contain two distinct antigen-binding arms, which enable them to bind to the target antigen while also activating an effector cell, which kills tumor cells. The primary antigen on the surface of the effector cell is called CD3, which is a popular target of immune cells. According to Coherent Market insights the Bispecific Antibodies Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. Many of these multi specific antibody formats have been developed over the past 30 years. These categories ...
Read more

Organic Milk Has Much Higher Concentration Of Iron, Vitamin E, And Polyunsaturated Fatty Acids Omega-3 And Omega-6 As Compared To Regular Milk

Image
  Organic Milk Organic Milk is milk made from livestock raised using organic farming practices. The use of the term "organic" is regulated by food authorities in most jurisdictions. Organic cows are not allowed to be given hormones, which stimulate milk production. Organic feed also must be grown without the use of synthetic pesticides. Organic cows must get a certain percentage of their diet from grazing, although most organic dairies supplement the grass with grain. However, organic grazing cows produce less milk than cows that eat a grain-based diet. Buying organic milk may be a better investment for your health. According to Coherent Market Insights the Organic Milk Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028. The standards for organic milk are stringent. To meet the organic standard, a dairy farm cannot use any form of animal growth hormones or antibiotics. Organic cows must spend at least 30% of their lives on pasture. C...
Read more